Abstract: Fourteen Sprague-Dawley male rats were randomly divided into 2 groups which were given CdCl2 at the doses of 0 and 1.5 mg /kg for 12 weeks. Before sacrifice, microCT scanning were performed on the proximal tibia and urine were collected for cadmium and N-acetyl-beta-D-glucosaminidase assay, then all of rats were sacrificed and blood was collected for biomarkers measurement; bone tissues were collected for bone mass, histology and biomechanical analysis. The cadmium in blood, urine, bone and kidney of rats treated with cadmium was significantly higher than those in the control group. The bone mineral density, and bone mineral ability of rats treated with cadmium were obviously decreased by 20%-50% compared to controls. Bone microstructure index and trabecular separation of rats treated with cadmium were obviously lower (-50%) and significantly higher (+150%) than that in the control group. Bone biomechanical property decreased by 30%-60% in cadmium treated rats compared to control. Tartrate-resistant acid phosphatase 5b and alkaline phosphatase levels of rats treated with cadmium were significantly higher than those in control, but serum osteocalcin level decreased greatly by cadmium. Obvious proximal tubule damage occurred after cadmium exposure. These observations gave clear and comprehensive evidence that cadmium exposure could induce itai-itai-like syndrome in male rats.
Introduction
Cadmium is a toxic trace elements widely existing in the environment and used broadly in industry. The waste air, water and residues discharged through mine exploitation and smelting could result in cadmium pollution. The cadmium existing in environment could enter into the body via food and water and be harmful to many system and organs. Bone is one of the target organs for cadmium toxicity [1] . It has been shown that cadmium could decrease bone mineral density, result in osteoporosis and increase the risk of bone fracture [2] [3] [4] [5] [6] [7] [8] .
Itai-itai disease was the most serious disease caused by cadmium exposure which appeared in the downstream basin of the Jinzu River in 1940s in Japan [9] [10] [11] . The syndrome is characterized by renal tubular dysfunction and bone damage (osteomalacia, osteoporosis and fracture) and had been found mostly occurred among middle aged and elderly women [5, 12] . A markedly increased excretion of urinary molecular weight proteins, such as ß 2-Microglobulin, and high serum alkaline phosphatase (ALP), is found in itai-itai disease patients. Severe skeletal deformities and multiple bone fractures were observed in older, postmenopausal women. Many studies had showed that women were more susceptible to Cd toxicity than men [13] [14] [15] [16] . Pregnancy, lactation, menopause and estrogen depletion caused by menopause might be important factors, both separately and in combination, influencing the bone effects of Cd in women. Recently, some studies in vivo indicated that cadmium may be a weak risk factor for osteoporosis or bone damage in males [5, 15] . However, few studies have investigated whether cadmium exposure could induce itai-itai disease in young males.
The mechanisms of Cd effects on bone are not completely clear, but several possibilities have been suggested [17] . Cadmium may have indirect and direct influence on bone. Cd induced bone damage may be mediated via renal dysfunction [18] . Cd could increase excretion of Calcium and reduce the generation of 1, 25(OH) 2 D in kidney. As a result, calcium uptake and reabsorption in gastrointestinal gut would decrease and lead to bone mineralization. However, recent epidemiological and vitro studies suggested that Cd may have direct effect on bone [6, 7, 19, 20] , including increased risk of fracture and disturbed metabolism of osteoblast and osteoclast.
In the present study, using an animal model, we observed the effects of relatively high level of cadmium exposure on kidney and bone, on bone mass, bone biomechanical property, bone microstructure and bone metabolism, to investigate whether cadmium exposure could induce itai-itai-like syndrome in young male rats and to test the probable mechanism.
Material and Methods

Experimental design
The study was approved by the Animal Care Committee of Fudan University. A number of fourteen 8-week-old Sprague-Dawley male rats weighing 180-200g were fed in the SPF animal facilities under conditions of 21±1°C and a light-dark (12:12-h) cycle at all times. After acclimatization to laboratory conditions for one week, the rats were randomly divided into 2 groups of 7 rats. Rats in the control group were injected subcutaneously with sodium chloride. Another group was given CdCl 2 by subcutaneous injection at the doses of 1.5 mg Cd/ kg body weight (BW) up to 12 weeks, five times per week. The body weight of each rat was obtained every week, and the volume of injection was adjusted to keep the levels of exposure constant. All the rats were administered intraperitonealy with tetracycline (30 mg/ kg bw) and calcein (5 mg/kg bw) at 14th days and 4th days before sacrifice.
Micro-CT analysis
At the 12 th week, microCT scanning was performed in four rats from each group (randomly selected) on the proximal tibia using Ge eXplore locus scanner (GE healthcare, USA) with an X-ray tube voltage of 80 kV and current 450 mA before sacrifice. Rats were anaesthetized by chloral hydrate and fixed on the scanning platform. A spatial resolution with a voxel size of 45 μm was selected. Structural parameters from the micro-CT was assessed using the software (Microview2.1.2) supplied by the manufacturer. Trabecular and cortical bone of the proximal tibia was reconstructed and calculated for analysis within a conforming volume of interest commencing at a distance of 1mm from the growth plate, and extending a further longitudinal distance of 0.5mm in the distal direction. Then, bone volume fraction (BV/ TV), trabecular thickness (Tb. Th), trabecular separation (Tb.Sp) and trabecular number (Tb.N), apparent (v-BMD) and tissue (t-BMD) bone mineral density were calculated using the software. Meanwhile, thickness of cortical bone was calculated using the same software.
Samples collection
At the 12 th week, after 24-h urine collection, all of rats were anesthetized using urethane and blood was collected from the carotid artery. To make sure that the vessels were cadmium-free, they had been washed with diluted nitric acid followed by deionized water. The blood sample collected without anticoagulant was clotted for serum isolation. Blood, serum and urine samples were distributed into aliquots and frozen at -80˚C until analyzed. The right femur, lumbar spines (L1-L5) were isolated from any soft tissues and wrapped in cold sodium chloride solution for biomechanical testing and bone mineral density measurement. L4 and the right tibia were obtained for bone histology analysis. L3 and the left femur were used for bone weight measurement after dissected free of soft tissues. Kidneys were harvested for histology and TEM analysis.
Cd analysis
Cd concentrations in blood, urine, bone and kidney were determined by Inductively Coupled Plasma Mass Spectrometry (ICP-MS, Thermo Elemental Co., Ltd. USA). Five hundred microlitres of whole blood and 1 ml of urine were digested using HNO 3 (70% HNO 3 for trace metal analysis). After partial evaporation, samples were cooled down, H 2 O 2 (36.5-38.0% for trace metal analysis) was added and the solution was totally evaporated. The precipitate was dissolved in 1ml HNO 3 and analysis was performed with ICP-MS. Concentrations were measured using a standard calibration curve.
The right tibia was ashed in a muffle oven at 600°C for 6h and then the bone was dissolved in 1ml HNO 3. The kidney was digested directly in HNO 3 using microwave oven. Consequently, the analysis was performed with ICP-MS. The detection limit for Cd using ICP-MS was 0.4ng/L.
Bone densitometry
L1-L5 were measured by dual energy X-ray absorptiometry (DEXA) using a Hologic QDR 4000 (USA) densitometer with small animal software. The coefficient of variation for the measurements was below 1%. All densitometrical parameters were analyzed by the same examiner and made on the same day.
Bone weight measurement
The L3 and left femur were dried in oven at 120°C for 1 h and then degreased in chloroform/methanol(v/v 3:1) solution for 72h. After being dried for 6h at 120°C, the bone weight was measured using Mettler Toledo balance (USA). Then the bone was put in a muffle furnace at 600°C for 6h and the bone ashed weight was measured using a scale.
Biomechanical test
The mechanical properties of the lumbar spine were evaluated basing on the compression test of the vertebral body (L5) performed using universal testing machine (Instron 5566) and coupled with computer for data acquisition and storage using Bullhill material testing software. The L5, located between two smooth steel places was compressed to failure at a displacement rate of 2 mm/min. During the test, the load-displacement curve was recorded using the test software. The mechanical properties of the L5 were evaluated basing on the following variables: Elastic modulus, compression strength, yield strength and crack energy. Meanwhile, the mechanical properties of left femur were evaluated in a three-point bending test with same machine at the displacement of 2mm/min until fracture occurred basing on the following variables: strain, stiffness, stress and bending load.
Bone histology
Hematoxylin and Eosin (HE) stain, Goldner'trichrome stain and Scanning Electronic Microscopy (SEM) were used for bone histology analysis. L4 was fixed in 10% formalin at 4°C for 72h and then decalcified in EDTA for 72h at room temperature, embedded in paraffin and sliced for HE stain. The right upper tibia was fixed in Million's solution at 4°C for 72h with the solution changed every 24h. The tibia was dehydrated through a series of ascending ethanol solution (40%-100%) and then cleared with dimethylbenzene, filtrated with methylmethacrylate, and embedded in methylmethacrylate. After polymerization, the blocks were trimmed with a saw to remove excess plastic. 8-μm-thick sections were obtained using a rotary microtome(Leica) for Goldner'trichrome stain. Meanwhile, 20-μm-thick slices were prepared for mineral apposition rate (MAR) analysis using fluorescence microscope (Nikon).
Biomarker analysis
Bone metabolism markers in serum were determined using different methods. Osteocalcin concentration in the serum was assayed using EIA methods (Rat-Mid osteocalcin, IDS, UK). The intra-assay CV of the method was 5.5%-7.7%, the recovery rate was 83%-106%. Tracp-5b in the serum was measured by EIA methods (RatTRAPTM Assay, IDS, UK).The intraassay CV of the method was 3.5%-5.8%, the recovery rate was 92%-105%. Alkaline phosphatase( ALP), calcium(Ca) and phosphorous (P) in serum were measured by Biochemical analyzer(Hitachi 7190).
Urinary N-acetyl-beta-D-glucosaminidase (U-NAG) was determined as described by Tucker et al (1975) used as indicators of renal dysfunction. Creatinine measurement was performed using Biochemical analyzer. The UNAG values were expressed as U/mmol creatinine.
Kidney histology
The right kidney was dissected and put on ice, then cut into pieces and fixed in 2.5% glutaraldehyde solution for Transmission Electronic Microscopy (TEM) analysis. The rest of the kidney was fixed in 10% formalin at 4°C for 72h, dehydrated through a series of ascending ethanol solution, embedded in paraffin and sliced for HE stain.
Statistical analysis
SPSS11.5 (SPSS Inc, Chicago, IL, USA) was used for statistical analysis. Data are expressed as mean f SD. To examine the differences between control and Cd-exposed groups, student's T test was conducted. P values below 0.05 were considered statistically significant.
Results
Body weight
The body weight of all rats increased during the experiment (Figure 1) . At the end-point of experiment, two of the rats in cadmium group died. We found that cadmium may influence the weight of rats. The body weight of rats treated with cadmium was obviously lower than those of control group during the whole experiment.
Exposure assay
At the 12 th week, we collected blood, urine, bone and kidney tissue for cadmium analysis. In control rats, the blood and urinary Cd concentration and Cd in bone and kidney were very low (Figure 2 ). Exposure to cadmium caused an obvious increase in body burden of this metal, as evaluated as blood and urinary Cd and its accumulation in femur and kidney. Cadmium levels in blood, urine, bone and kidney were much higher in the exposure group as compared with the control.
Bone mass
BMD of lumbar was measured using DEXA. The general volumes of bone of rats treated with cadmium were obviously smaller to those in control. BMD of groups treated with cadmium decreased by about 20% compared to the control group (Figure 3) . After drying and ashing the lumbar spine and the femur, the weight of lumbar bones and femur of groups treated with cadmium was significantly decreased by about 40% and 30%, respectively, compared with that of the control group (Figure 4 ).
Biomechanical properties
Bone weakness and brittleness had been observed during the progress of sample treatment. Then, using universal material test machine, we measured the mechanical properties of the femur and lumbar spine ( Figure 5 ). All of the measured parameters describing the mechanical properties of L5 and the femur in the group treated with cadmium were decreased compared to those of the control. For L5, elastic modules, crack energy, compression strength and yield strength of rats treated with cadmium decreased by about 60% compared to control. For femur, load, stiffness, strain and stress of rats treated with Cd decreased by about 40%, 40%, 30% and 60%, respectively, compared to those in control. (0) and Cd treated rats. Goldner' trichrome stain for tibia (A); MicroCT analyses were performed in four rats of 0 and 1.5mg Cd/kg bw groups (randomly selected) on the proximal tibia using Ge eXplore locus scanner (GE healthcare) basing on bone volume fraction, bone trabecular analysis (B). Data were shown as mean ± SD (n = 4-7). *, p < 0.05, compared with 0.
Figure 9.
After marked with tetracycline and calcein, bone mineral ability was evaluated by mineral apposition rate in tibia using fluorescent microscopy.
Bone histology and histomorphormetry
Bone morphometry analysis showed that BV/TV, Tb.N, cortical thickness and mineral apposition rate (MAR) were decreased (-50%, -50%, -20% and -40%, respectively) and Tb.Sp were increased (+150%) in Cd exposed groups compared to that of control group (Figure 6-9) . HE stain and SEM scanning for lumbar and Goldner' trichrome stain for tibia also reveals that Tb.N and Tb.Th were decreased and Tb.Sp was increased compared to that of the control group ( Figure 6 ). Otherwise, trabecular conjunction points were obviously decreased and dissociated ends were significantly increased in groups treated with cadmium in 2 dimensional and 3 dimensional images.
Kidney histology
In the control group, the renal glomerulus had normal morphological structure and the cavity of Bowman' capsule was clear; no obviously abnormal change was found in renal tubule ( Figure 12A ). When exposed to 1.5 mg Cd/kg, it was clear that the glomerulus had shrunk and the nuclei were irregular. Obvious renal tubule damage, in the form of cell denaturalization and necrosis occurred in Cd treated rats. TEM image also revealed that microvilli of proximal tubule epithelial cell were shortened and obvious necrosis was found in Cd exposed group. Meanwhile, it was clear that mitochondria were swollen, necrotic and vesicular resulted from Cd exposure.
Biochemical biomarkers
There was no obvious difference between serum Ca and P level in the control or cadmium exposure group (Figure 10) . However, the Tracp 5b and ALP level were much higher in the cadmium exposure group compared with that in control (Figure 11 ). High bone remodeling status occurred after cadmium exposure. Meanwhile, OC level significantly decreased in rats exposed to cadmium compared to those in control. There was a statistically significant increase in U-NAG in Cd-treated rats, by 5-fold, compared to that in control ( Figure 12B ).
Discussion
It had been suggested that cadmium retention was generally higher in women than in men, and the severe cadmium-induced Itai-itai disease was mainly a woman's disease [14] . For a half century, it had been known that women may be more affected by cadmium than men [14, 21] . Recently, experimental studies suggested that cadmium effects on serum levels of calciotropic hormones and disorders in calcium and phosphate metabolism were higher in female than in male rats [12] . Epidemiological studies also revealed that women were at a higher risk for cadmium toxic effect than men [13, 14, 16] Decreased bone mineral density and increased risk of bone fracture were mostly found in postmenopausal women. Some studies had shown that the uptake of cadmium in women was higher than men and that there may be a gender difference in susceptibility to cadmium-induced toxicity [12, 14] . The disturbances of bone tissues metabolism may induce their deformities and fracture. Gender may variously influence bone properties, such as bone structure and mineralization.
In this study, we found cadmium could induce itai-itailike syndrome in young male rats at relatively high level (1.5mg/kg bw). Bone mass (bone mineral density and bone weight), bone mechanical properties, and bone microstructure were severely damaged by cadmium exposure. Meanwhile, obvious renal dysfunction, especially for tubular damage, appeared in male rats exposed to cadmium.
The main symptoms of itai-itai diseases were renal failure, osteomalicia, bone pain and bone fracture. In the present study, obvious kidney damage was found in cadmium-treated rats, particularly tubular damage, in the form of denaturalization and necrosis. The U-NAG level in Cd-treated rats was about 5-fold higher compared to that in control. The BMD and bone weight of rats treated with cadmium was significantly lower than that of control, reduced by 20-50%, which means that osteomalicia may have occurred.
Biomechanical integrity of the bone is an aspect of bone tissue properties which is a with regards to vulnerability to fracture [22] . Weakening in the bone biomechanical properties, including especially a decrease in the yield and fracture strength, indicates an enhanced bone susceptibility to fracture. Moreover, further study also revealed that cadmium influence cancellous bone and cortical bone mechanical property [5, 23] . The rats treated with 1.5mg/kg bw Cd had weakened compression strength and yields strength compared with control which suggested that the L5 and femur became brittle, especially for L5. The biomechanical parameters in femur and spine decreased obviously by 30%-60% in cadmium treated rats compared to those in control. Based on the measurement performed, it seems that the lumbar spine was more susceptible to fracture than other evaluated regions, such as femur. Some studies had suggested that trabecular bone was more metabolically active and susceptible to fracture than cortical bone [5, 23, 24] .
Bone fracture mainly depends on bone tissues properties. Bone microstructure seems to be one of important factors to understand the mechanisms of bone fragility. It had been indicated that microstructural alteration is an important determinant of bone fragility, independently of bone density [25, 26] . However, few studies had investigated the change of bone microstructure after cadmium exposure. In this study, Figure 12 . Cadmium induced kidney injury. Hematoxylin and Eosin (HE) stain and Transmission Electronic Microscopy (TEM) analysis for histological damage (A). Cadmium burden in kidney and Urinary NAG were determined by Inductively Coupled Plasma Mass Spectrometry and colorimetric methods as biomarkers (B). *, p < 0.01 vs. 0 using 2 dimensional and 3 dimensional methods, we observed cadmium impacts on bone structure. It had been shown that bone microstructure index (bone fraction volume, trabecular number) and Tb.Sp of rats treated with cadmium were obviously lower (-50%) and significantly higher (+150%) than that in control, respectively. 2D and 3D histology investigation (HE staining, microCT scan and SEM image) also revealed the damage of bone microstructure (trabecular conjunction points decreased and dissociated ends increased) caused by cadmium exposure. Obvious bone structural damage was found in cadmium treated rats.
The mechanism of cadmium on bone tissues is not understood completely. It seems that cadmium could inhibit bone formation and stimulating bone reabsorption via influencing on activity and metabolism of osteoblast and osteoclast [7, 20, 28] . Tracp 5b is one kind of new bone metabolic biomarkers which can be specifically secreted by osteoclast. Recent studies revealed that Tracp 5b could reflect the number and activity of osteoclasts and also could indicate bone mineral loss [29] . Tracp 5b levels in the serum could be used to evaluate the number of osteoclasts instead of histology assay [29] [30] [31] . In the present work, we found that cadmium could increase Tracp 5b level. The concentration of Tracp 5b in serum was about 1.5 fold higher in cadmium rats compared with control group. Obviously, cadmium could increase bone reabsorption ability by increasing osteoclasts number or activity. Otherwise, OC level in serum of rats treated with cadmium was significantly lower than those in control which indicated that cadmium could inhibit bone formation at relative high level.
Previously, it had been thought that Cd induced bone damage might be mediated via renal dysfunction [18] . Cd could increase excretion of Ca and reduce the generation of active vitamin D in kidney. As a result, calcium uptake and reabsorption were decreased. Bone formation and mineralization were inhibited. Cd primarily does harm to the kidney, followed by bone damage as a secondary effect [32] . At present, some epidemiological studies in Europe suggested low level of Cd exposure which can not cause kidney damage could decrease height, BMD and increase the risk of bone fracture [6, 7] . A few studies in vitro also suggested that cadmium could alter metabolism and activity of osteoblasts [19, 20] and osteoclasts [20, 28] . In other words, Cd may have the direct influence on bone. We hypothesized that the mechanism of cadmium on bone may be related to dosage. Renal dysfunction and uncoupling of bone formation and reabsorption caused by cadmium together may play curial role in itai-itai disease, especially at relative high level of exposure.
In this study, we observed that cadmium exposure could induce itai-itai-like syndrome in male rats. These results demonstrated that itai itai disease could be reproducible in male rats by repeated subcutaneous injection of cadmium. Renal dysfunction and uncoupling of bone formation and reabsorption may be important mechanism of cadmium toxic effects on bone.
